UCA1 and ovarian cancer: In two other ovarian cancer cell lines, OAW42 and OVCAR3, both sensitive to cisplatin treatment, UCA1 expression levels were around 100‐ and 200‐fold lower respectively than in OAW42‐R (Fig. 1B).